SCHEMBL7953785

SCHEMBL7953785

CCc1ccccc1Oc1cc[c]cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.44
SLC6A4 P31645 4/20 0.44
SLC6A3 Q01959 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.42
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
OXTR P30559 1/20 0.38
HPGD P15428 2/20 0.38
ATM Q13315 1/20 0.38
NISCH Q9Y2I1 1/20 0.38
AR P10275 1/20 0.36
KDM4E B2RXH2 1/20 0.35
P2RY1 P47900 1/20 0.34
SYK P43405 1/20 0.34
DCK P27707 1/20 0.34
SLC1A5 Q15758 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC22A12 Q96S37 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897755 0.79 SMN1; SMN2 (0.55) SLC6A2SLC6A4SLC6A3HPGDAR
SCHEMBL5023935 0.77 KDM4E (0.51) SLC6A2SLC6A4SLC6A3L3MBTL1MAPT
SCHEMBL1711665 0.76 MEN1 (0.53) SLC6A2SLC6A3L3MBTL1MAPTKDM4E
SCHEMBL693585 0.76 KMT2A (0.49) SLC6A2SLC6A4SLC6A3HPGD
SCHEMBL2266338 0.75 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3L3MBTL1MAPT
SCHEMBL2902921 0.73 KDM4E (0.41) SLC6A4L3MBTL1MAPTNPSR1HPGD
SCHEMBL2901270 0.73 MAP4K4 (0.46) HPGDDCKTSHRSLC22A12
SCHEMBL5361562 0.73 MAP4K4 (0.44) KDM4E
SCHEMBL475213 0.73 L3MBTL1 (0.57) SLC6A2SLC6A4SLC6A3L3MBTL1MAPT
SCHEMBL2751860 0.72 SMN1; SMN2 (0.41) L3MBTL1MAPTKDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235758-B1 CENTRAL NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-22 US disclosed
EP-0808312-B1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 2000-11-02 EP disclosed
US-5990133-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS ANXIETY OR DEPRESSION SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-23 US disclosed